| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |